for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Catalent to make active ingredient for AstraZeneca's COVID-19 vaccine candidate

Aug 24 (Reuters) - Catalent Inc said on Monday it will manufacture active ingredient for AstraZeneca Plc and the University of Oxford’s COVID-19 vaccine candidate.

It will be made at Catalent’s commercial gene therapy manufacturing facility located in Harmans, Maryland, the company said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up